In recent years, great progress has been made in understanding the genetics of metastatic prostate cancer which has translated into the development of new precision therapies.
Kerry R. Schaffer, MD
Advertisement
Articles by Kerry R. Schaffer, MD
Advertisement
Latest Updated Articles
New Framework for Genetic Testing in Prostate Cancer Takes ShapeOctober 7th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Sacituzumab Govitecan Monotherapy and In Combination With Pembrolizumab in Frontline TNBC
2
Dr Tolaney on the FDA Approval of First-Line Sacituzumab Govitecan Plus Pembrolizumab for TNBC
3
Dr Morgans on the Design of the ARACOG Trial in Prostate Cancer
4
Daratumumab Retreatment Displays Activity in Relapsed Myeloma Following Continuous Frontline Therapy
5